Does Mounjaro Make You Feel Jittery — and Should You Worry?

Jitteriness is not a listed side effect of Mounjaro, but low blood sugar (hypoglycaemia) (which can cause shakiness) is a recognised risk, particularly in people also taking insulin or a sulfonylurea.
People without diabetes taking Mounjaro for weight management have a very low risk of hypoglycaemia on tirzepatide alone, according to the SURMOUNT programme data.
The feeling often resolves within days to a couple of weeks as the body adjusts to slower gastric emptying and changed appetite signals.
Persistent or severe shakiness, sweating, confusion or a racing heart should prompt you to contact your prescriber or seek medical help promptly, do not wait for your next appointment.

Mounjaro does not list jitteriness as a recognised side effect in its clinical data, but some people do report a shaky or wired feeling, particularly in the first few weeks. That sensation usually traces back to one of two things: a rapid drop in blood-sugar levels, or the general physiological adjustment to a new medicine. Understanding which is which matters — and the broader experience of how Mounjaro feels day-to-day is something many patients find reassuring to read before their first pen. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber assesses whether it is suitable for you before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the jittery feeling actually is, and when it needs attention

You inject your first dose, and a few hours later you feel oddly wired

That is the scenario a lot of people describe. Not the nausea they were warned about, but a subtle shakiness, hands slightly unsteady, heart rate a touch elevated, a buzzing quality to the afternoon. It is unsettling precisely because it does not appear on the list of common side effects they printed from the leaflet.

Tirzepatide slows the rate at which food leaves the stomach and changes the signals your gut sends to your brain about hunger and fullness. If you have eaten less than usual (or not much at all, because the nausea put you off) your blood glucose can dip lower than your body is used to. That dip triggers the same stress-hormone response as conventional low blood sugar: adrenaline rises, and adrenaline causes shakiness. It is worth reading more about how Mounjaro affects appetite and fullness to understand why meals can shrink so sharply in the first weeks.

This is not the same as clinical hypoglycaemia in most cases, it is more a relative drop, your body recalibrating to a new normal. Eating a small, protein-containing meal at regular intervals tends to settle it. If you are also taking insulin or a sulfonylurea for diabetes, the risk of genuine low blood sugar is higher and your prescriber should know about any shaky episodes promptly.

Why tirzepatide can mimic anxiety symptoms even when blood sugar is stable

The GLP-1 pathway that tirzepatide activates has effects beyond the gut. Some people notice a heightened physiological alertness, a feeling that sits somewhere between mild anxiety and the buzz after a strong coffee. The mechanism of tirzepatide involves both the GIP and GLP-1 receptors, and early activation of these pathways can affect gastric nerve signalling in ways that feel unfamiliar.

A question our prescribers hear most weeks is whether the jittery feeling means something is going wrong. In the majority of cases, it does not. It tends to peak in the first few days after each dose or after a dose increase, then settle as the body adapts. Keeping meals small and regular (particularly at the start) and staying properly hydrated both help. Caffeine can amplify the sensation; some people find cutting back slightly during the first week of a new dose makes a real difference.

The flu-like feeling some people describe early in treatment can overlap with this: headache, fatigue, and that general sense of being off-balance. These are different mechanisms but the timing is often the same, which is why the first couple of weeks feel busier symptom-wise than later months.

When the shakiness is a signal worth acting on

Most jitteriness on Mounjaro is self-limiting and responds to a light snack and rest. But there are patterns that should not be waited out. Shakiness accompanied by sweating, confusion, a pounding heart, pale skin, or difficulty concentrating points to genuine low blood sugar and needs immediate attention: a fast-acting carbohydrate (glucose tablets, fruit juice) followed by contact with your prescriber or, if symptoms are severe, urgent medical help.

Shakiness that persists beyond the first few weeks, or that worsens rather than improves, is also worth raising directly with whoever oversees your prescription. The full picture of how Mounjaro affects people physically covers a wider range of sensations worth knowing. For anyone who experiences low mood or feels noticeably anxious alongside the physical symptoms, that is equally worth mentioning to a prescriber, the two can reinforce each other.

The NHS medicines page for tirzepatide lists the side effects that have been reported and gives clear guidance on which symptoms warrant calling 999 or 111. On a prescription medicine like this, that page is worth bookmarking. You can also report unexpected side effects directly to the MHRA via the Yellow Card scheme, it contributes to national safety monitoring and takes only a few minutes.

Putting it in context: what this means for your treatment

The jittery feeling, where it occurs, is almost always a sign of adjustment rather than harm. Tirzepatide is a significant shift in how the body handles food and appetite, and the first few weeks reflect that. Most people find that by the time they reach their second or third pen the sensation has settled considerably, the less-discussed physical changes like temperature sensitivity often outlast it.

If you are thinking about starting treatment and want to understand what to expect from week one onwards, our clinical team at nume reviews every consultation personally. Cost of treatment and what is included in the private prescription price is covered on the weight-loss treatments page. That same page is the starting point if you want to check your eligibility, there is no obligation and no automated triage; a real prescriber reads your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions